The National Cancer Institute (NCI), part of the National Institutes of Health (NIH), has announced its intent to publish a Notice of Funding Opportunity (NOFO) for the Academic Career Excellence (ACE) Award (K32 - Independent Clinical Trial Required). This opportunity, currently in the forecast stage, aims to support early-stage postdoctoral researchers transitioning from graduate studies into independent cancer research careers. The ACE Award will provide funding intended to enhance both scientific and career development training for eligible candidates. It is anticipated that the official announcement will be released on April 1, 2025, with applications due by June 12, 2025.
The primary purpose of the ACE Award is to facilitate early postdoctoral training for individuals dedicated to cancer research. This award is specifically designed for those within twelve months of transitioning to a postdoctoral position or within the first two years of their postdoctoral training. The award supports candidates who have already selected a postdoctoral research group and crafted a detailed research and training plan. The award encourages rigorous research engagement and structured mentorship to build the foundation for a successful career in cancer research.
This funding opportunity falls under the category of Health, specifically focusing on cancer research workforce development. While specific award amounts and the total funding available have not yet been disclosed, the assistance is classified as a grant under the discretionary category. Matching funds are not required for applicants. Funding is anticipated to begin with awards being issued around March 2, 2026, marking the official start date for supported projects.
Eligibility for the ACE Award is broad and includes a range of institutions and organizations. Public and private institutions of higher education, nonprofits with 501(c)(3) status, state and local government entities, tribal governments and organizations, housing authorities, and both small and other for-profit businesses may apply. Detailed eligibility criteria will be further clarified in the full Notice of Funding Opportunity when published.
Applicants must submit their completed applications by the estimated due date of June 12, 2025. Though no specific submission instructions or required attachments are listed in the forecast, the full NOFO will contain application procedures and necessary forms. It is also anticipated that evaluation criteria will include research plan quality, career development potential, and alignment with NCI’s mission.
Important dates to note include the estimated post date of April 1, 2025, application due date of June 12, 2025, estimated award date of March 2, 2026, and project start date of March 2, 2026. This funding opportunity is expected to recur annually, aligning with the NIH fiscal year cycle.
